HSINCHU, Taiwan and WUHAN, China, January 1, 2018 -- JHL Biotech announced that Rong Chen has been appointed Chief Medical Officer effective January 1. As CMO, Dr. Chen will oversee... read more →
JHL Biotech, Inc. (“JHL”, 6540. TWO) was awarded a top 20 ranking in Deloitte Touche Tohmatsu Limited’s 2017 Asia Technology Fast 500™ list. This annual ranking compares the fastest growing... read more →
Singapore and Hsinchu, Taiwan, 14 November 2016 – ASLAN Pharmaceuticals (ASLAN), a biotech company focused on the development of immunotherapies and targeted agents for Asia prevalent tumour types, and JHL Biotech,... read more →
喜康武汉KUBio工厂获得2016卓越设施设计奖 一、武汉神级玩家 - 喜康生物获2016卓越设施设计奖 (more…)
Hsinchu, Taiwan and Wuhan, China, November 1st, 2016 – JHL Biotech (“JHL”, Stock Code: 6540.TWO) has announced that WeiDong Cui, Ph.D. has joined JHL Biotech as Corporate VP of Manufacturing and Technology,... read more →
Hsinchu, Taiwan and Wuhan, China, October 11th, 2016-- JHL Biotech won the 2016 Bio Processing International award for Excellence in Facility Design or Retrofit. The award, granted every two years, recognizes... read more →
WUHAN, China, June 13, 2016—JHL Biotech, Inc. (TWSE: 6540) (“JHL”) announces that it has entered into a contract manufacturing agreement with BeiGene, Ltd. (NASDAQ: BGNE) (“BeiGene”) for development and IND-enabling... read more →
GE Healthcare delivers world’s first modular manufacturing solution based on single-use bioprocessing technology in just 18 months (JHL Biotech's Commercial GMP Facility -Wuhan, China). CHALFONT ST. GILES, UK and WUHAN,... read more →
Hsinchu, Taiwan – March 1, 2016 - JHL Biotech, Inc. (Stock Code: 6540.TWO) announced it has entered into a contract manufacturing master service agreement with Affinita Biotech. The agreement covers... read more →
Wuhan, China and Amersham, UK; 25 February 2016: JHL Biotech (TPEx: 6540) and GE Healthcare’s Life Sciences business (NYSE: GE) are proud to announce mechanical completion of JHL Biotech’s JHL-1... read more →